Related Experiment Video
Updated: Jul 12, 2026
05:07
Characterizing Extracellular Vesicles from Biological Fluids
Published on: February 28, 2025
Advancements in extracellular vesicle research.
Bingrui Li1, Valerie S Kalluri1,2, Alissa M Weaver3,4
1Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Extracellular Vesicle
|July 10, 2026
Summary
The American Association of Extracellular Vesicles meeting advanced extracellular vesicle (EV) science, highlighting progress in diagnostics and therapeutics. Discussions focused on overcoming challenges in EV isolation, characterization, and clinical application for personalized healthcare.
Area of Science:
- Extracellular Vesicle (EV) Science
- Biomedical Research
- Cellular Biology
Background:
- Extracellular vesicles (EVs) are key mediators of intercellular communication, involved in numerous physiological and pathological processes.
- EVs hold significant promise as diagnostic biomarkers and therapeutic delivery agents in precision medicine.
- Challenges remain in EV heterogeneity, isolation, purification, and standardization of characterization protocols.
Purpose of the Study:
- To convene global experts to advance the field of extracellular vesicle (EV) science.
- To foster collaboration and exchange insights on the latest discoveries and methodologies in EV research.
- To address challenges and accelerate the translation of EV-based approaches into clinical applications.
Main Methods:
- Keynote addresses on EV heterogeneity, biogenesis, and immunomodulatory capabilities.
- Sessions showcasing cutting-edge technologies for EV isolation and characterization.
- Presentations on novel EV engineering for therapeutics and industry-scale production.
Main Results:
- Demonstrated significant progress in understanding EV complexity and refining isolation/analysis techniques.
- Highlighted novel mechanisms of EV-mediated immune modulation and disease progression.
- Showcased advancements in bioengineering and scalable production for EV therapeutics.
Conclusions:
- The field is transitioning from theoretical potential to tangible applications for EV-based diagnostics and therapeutics.
- Global collaboration and industry-academia partnerships are crucial for overcoming current challenges.
- The AAEV community is poised to accelerate the integration of EV approaches into mainstream healthcare.
Related Concept Videos
01:36Overview of Exosomes
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
01:38Intralumenal Vesicles and Multivesicular Bodies
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...